Clinical Trials Directory

Trials / Completed

CompletedNCT03662243

Treatment for Reading and Writing Deficits Following Acquired Brain Injury

Status
Completed
Phase
Study type
Observational
Enrollment
2 (actual)
Sponsor
Quality Living, Inc. · Academic / Other
Sex
All
Age
14 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Many people with acquired brain injuries have deficits in reading decoding, reading comprehension, and written expression. Alexia is a phenomenon in which a person who previously could read has trouble doing so after having sustained a brain injury; likewise, agraphia is an acquired writing problem affecting one or more aspects of written communication. Alexia and agraphia sometimes co-occur with one another and/or with other language challenges, but they can also occur as isolated phenomena. Methods to treat alexia and agraphia often focus on single intervention techniques that address aspects of reading or writing in isolation-such as matching written and spoken letters or letter sounds, performing choral reading, tracing letters, etc. Existing research suggests that the effectiveness of these techniques is limited. However, when used in combination, such techniques may promote improved reading and written communication skills. As such, the purpose of this research is to determine the extent to which a multicomponent intervention program improves the reading and writing capabilities of people with acquired alexia and/or agraphia.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMulticomponent reading and writing treatmentIntervention procedures incorporated into the program include drilling on sight words to improve immediate recognition of common words; engaging in Multiple Oral Reading procedures to increase reading fluency; practicing oral spelling of sight words to improve spelling accuracy; generating written sentences to improve accurate spelling and use of written conventions (e.g., punctuation, capitalization); and summarizing and subsequently writing sentences about read material to establish strategies to enhance reading comprehension and promote written expression.

Timeline

Start date
2018-08-30
Primary completion
2020-09-15
Completion
2020-09-15
First posted
2018-09-07
Last updated
2021-03-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03662243. Inclusion in this directory is not an endorsement.